Perrigo Company plc (LON:0Y5E)

Market Cap	1.75B +16.2%
Revenue (ttm)	3.09B -4.5%
Net Income	-1.34B
EPS	-9.55
Shares Out	n/a
PE Ratio	n/a
Forward PE	7.25
Dividend	0.87 (7.02%)
Ex-Dividend Date	Nov 27, 2026

Volume	82
Open	17.25
Previous Close	16.61
Day's Range	16.29 - 17.25
52-Week Range	9.28 - 17.25
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2026

About Perrigo Company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pai...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1887
• Employees: 8,100
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Y5E

Financial Performance

In 2025, Perrigo Company's revenue was $4.25 billion, a decrease of -2.75% compared to the previous year's $4.37 billion. Losses were -$1.43 billion, 729.7% more than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error